Personnel Information

写真a

KOIKE Ryuji


Job title

Professor

Birth date

1961

Laboratory Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

Laboratory Fax number

+81-3-5803-0396

Mail Address

koike.rheu@tmd.ac.jp

Research Areas, Keywords

medicine, rheumatology, infectious diseases, clinical pharmacology

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1987, Graduated

Degree 【 display / non-display

  • M.D., Ph.D., Tokyo Medical and Dental University

Campus Career 【 display / non-display

  • 1987.06
    -
    1988.06
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Department of Internal Medicine, Trainee Resident
  • 1991.01
    -
    1992.03
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Department of Internal Medicine, Senior Resident
  • 2005.04
    -
    2007.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Bio-Environmental Response, Rheumatology, Project Associate Professor
  • 2005.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Endowed Departments, Department of Pharmacovigilance, Project Associate Professor
  • 2007.04
    -
    2017.03
    Tokyo Medical and Dental University, Research and Industry-University Alliance Organization, a, Professor

display all >>

External Career 【 display / non-display

  • 1987.05
    -
    1988.06
    , Trainee Resident
  • 1991.01
    -
    1992.03
    , Senior Resident
  • 2005.04
    -
    2007.03
    , Project Associate Professor
  • 2007.04
    -
    Now
    , Associate Professor
  • 2009.04
    -
    2013.09
    , Associate Professor

display all >>

Academic Society Affiliations 【 display / non-display

  • American College of Physicians

Research Areas 【 display / non-display

  • Collagenous pathology/Allergology

  • Medical pharmacy

  • Infectious disease medicine

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  • Nukui Y, Ayibieke A, Taniguchi M, Aiso Y, Shibuya Y, Sonobe K, Nakajima J, Kanehira S, Hadano Y, Tohda S, Koike R, Saito R. Whole-genome analysis of EC129, an NDM-5-, CTX-M-14-, OXA-10- and MCR-1-co-producing Escherichia coli ST167 strain isolated from Japan. Journal of global antimicrobial resistance. 2019.07; 18 148-150. ( PubMed, DOI )

  • Takagi Masatoshi, Ogawa Chitose, Aoki-Nogami Yuki, Iehara Tomoko, Ishibashi Eri, Imai Minoru, Kihara Tetsuro, Nobori Kiyoshi, Hasebe Kazuhisa, Mizutani Shuki, Kimura Toshimi, Nagata Masashi, Yasuhara Masato, Yoshimura Kenichi, Yorozu Pariko, Hosoi Hajime, Koike Ryuji. Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol BMC PEDIATRICS. 2019.01; 19 (1): 31. ( PubMed, DOI )

  • Kameda Hideto, Fujii Takao, Nakajima Ayako, Koike Ryuji, Sagawa Akira, Kanbe Katsuaki, Tomita Tetsuya, Harigai Masayoshi, Suzuki Yasuo, Japan College of Rheumatology subcommittee on the guideline for the use of methotrexate in patients with rheumatoid arthritis. Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis(和訳中) Modern Rheumatology. 2019.01; 29 (1): 31-40. ( ichushi )

  • Kasai S, Sakai R, Koike R, Kohsaka H, Miyasaka N, Harigai M. Higher risk of hospitalized infection, cardiovascular disease, and fracture in patients with rheumatoid arthritis determined using the Japanese health insurance database. Modern rheumatology. 2018.11; 1-7. ( PubMed, DOI )

  • Hideto Kameda, Takao Fujii, Ayako Nakajima, Ryuji Koike, Akira Sagawa, Katsuaki Kanbe, Tetsuya Tomita, Masayoshi Harigai, Yasuo Suzuki, . Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis. Mod Rheumatol. 2018.05; 1-10. ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • F. Hirano, W. Yokoyama, H. Yamazaki, K. Amano, Y. Kaneko, A. Kawakami, T. Matsui, R. Sakai, R. Koike, N. Miyasaka, M. Harigai. SDAI REMISSION AT WEEK 24 IS A PREDICTOR OF GOOD FUNCTIONAL AND STRUCTURAL OUTCOMES AT WEEK 72 IN A T2T IMPLEMENTING COHORT. EULAR2015 2015.06.11 Rome

Awards & Honors 【 display / non-display

  • Evergreen Award,American College of Physicians,2007.04

 

Performance of duties 【 display / non-display

  • Chief physician of Department of Medicine and Rheumatology,2018.04 - Now